Episodi

  • The Parallel System
    Nov 13 2026

    Got something to say to this podcast? Send a voicemail, and you might hear yourself on the next episode!

    Last week, we traced how supply chains fail agricultural workers. But what happens when care is physically present, yet remains out of reach? Over 476 million Indigenous people—roughly 6% of the world—navigate this paradox.

    In Episode 2 of The Health Ledger, we investigate The Parallel System. Journeying from the Arctic’s Sámi to Central Africa’s Batwa, we map how cultural exclusion and state absence fracture care. We also explore how landmark studies like SAMINOR offer a vital bridge for global health practitioners studying populations long excluded from the health ledger.

    Join us as we continue this month’s journey to uncover why systems disconnect.

    The Triad returns with Erin Rodgers on air quality, hemp, and retractions. Shehnoor nearly forgot The Triad and Erin tried to help, or added to the curiosity? Listen to it all.

    A Note on Cultural Competence from our studio.

    We are deeply conscious that in this global audio journey, I may have mispronounced certain names, places, or cultural terms. We view this as an ongoing learning process. If you notice any mispronunciations, we warmly welcome your corrections, so we can ensure our descriptions of global communities remain accurate, respectful, and culturally sensitive.

    Mostra di più Mostra meno
    20 min
  • The Missing Vial
    Nov 6 2026

    Got something to say to this podcast? Send a voicemail, and you might hear yourself on the next episode!

    The village football team is missing its young men. They are part of the largest global community: nearly one billion people whose daily way of life sustains the global food chain. Living and working in the world's most vulnerable environments, they face profound health risks. Yet, when emergencies strike, the medicine exists—but the supply chain ends where their official record ends. In Episode 1 of The Health Ledger, we journey from rural clinics lacking antivenom to the developed world, where systemic barriers still block timely care. We explore why the population that feeds us remains invisible to the systems meant to protect them.

    Includes The Dispatch by the practicing physician Dr. Bilal Zafar on how the under-representation of several global communities in clinical research shapes his daily practice.

    Mostra di più Mostra meno
    18 min
  • The Health Ledger: Charting the Subpopulations of a Changing World
    Nov 4 2026

    Got something to say to this podcast? Send a voicemail, and you might hear yourself on the next episode!

    Starting November 6 2026

    Mostra di più Mostra meno
    3 min
  • The Last Mile
    Oct 30 2026

    Got something to say to this podcast? Send a voicemail, and you might hear yourself on the next episode!

    Today we publish the final episode of The Molecular Pipeline, concluding five consecutive seasons since June 2026. We walk the last mile: through distance, darkness, insurers, and shortages, to understand why a medicine that works can still fail to arrive. The last mile is not a natural feature of the landscape; it is built by decisions.

    Also today, Erin Rodgers presents the Spotlight: a groundbreaking study mapping 25,000 film scripts across 88 countries to reveal how modern cinema shapes our perception of aging.

    The pipeline works. The disease did not. Listen now.

    Mostra di più Mostra meno
    15 min
  • The Gatekeepers
    Oct 23 2026

    Got something to say to this podcast? Send a voicemail, and you might hear yourself on the next episode!

    For thirty years, Juan wrote the standards. In his final year, he tried to make his agency faster.

    The hardware arrived. The backlog cleared. Reviews that took months took days.

    Then the Phase IV data came in — and the drugs worked. The wards were still full.

    This is the story of a regulator who perfects his gate, then discovers the gates he cannot reach: housing, prisons, food, labour, trade. A memo that is acknowledged and set aside. A labelling rule drafted on the last day.

    And a question the entire pipeline will have to answer: what happens when the medicine works, and the disease does not?

    And Erin Rodgers returns with The Triad — three biomedical updates, three keywords: telemedicine, drinking, the turf.

    Mostra di più Mostra meno
    14 min
  • The Human Trial
    Oct 16 2026

    Got something to say to this podcast? Send a voicemail, and you might hear yourself on the next episode!

    I thought the hardest part was over. Then the real work began.

    This is a first-hand account of a large Phase 3 global randomized clinical trial — the stage where a drug proves itself in thousands of patients, or disappears. From a site with no trained staff, one refrigerator on the fourth floor, and a community that trusted us before we trusted ourselves. And Amara, a grandmother who read the consent form slowly and asked the question no one could dodge.

    Also: Spotlight — a self-care toolkit for reducing antimicrobial resistance at home. And a memorable 3-liner by Erin Rodgers on the Phase III randomized clinical trials.

    The rest belonged to the gatekeepers.

    Mostra di più Mostra meno
    17 min
  • The Guinea Pig
    Oct 9 2026

    A lamb has bolted the barn door.

    The bacteria told her machines can now do what animals have done for a century. So she will not bleed.

    Six sheep wait outside. Two guinea pigs watch from the corner — they have seen it all before.

    What follows is a rare dialogue between species: an old ram, a young striker, and a flock asking whether biopharma still needs them as technology reshapes the pipeline, diseases keep evolving, and nations compete for scarce resources.

    Erin Rodgers wondered if the lamb had read our running order. She had not. But the coincidence holds: the farm, dental chair anxiety, respiratory health.

    Mostra di più Mostra meno
    17 min
  • The Target
    Oct 2 2026

    Got something to say to this podcast? Send a voicemail, and you might hear yourself on the next episode!

    A Himalayan lion watches a road cut through a valley he has known since cubhood. A biochemist climbs to meet him. Between them sits a question that decides which diseases get studied — and which are left behind.

    Every medicine begins with a target. A lock in the body — an enzyme, a receptor, a gene. The key must fit. But the lock must be chosen first. And choosing is excluding.

    Of every ninety molecules sent toward the clinic, nine arrive. The rest die in what the industry calls the Valley of Death. Meanwhile, the forests that gave us half of our anticancer drugs are thinning, and regulators move at speeds that leave whole nations waiting.

    The Molecular Pipeline begins where every medicine begins: with a decision about what to study — and what to leave behind.

    The forest was the first pharmacy.

    Also includes moments of Erin's curiosity and empathy for the Himalayan lion and his visitor. And don't miss the extraordinary Dispatch sent by Dr Bilal Zafar on the move in the company of crickets.

    Mostra di più Mostra meno
    15 min